CAICaris Life Sciences, Inc.

$5B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$348M+18.4% YoY

Gross Profit

$169M48.6% margin

Operating Income

$106M30.3% margin

Net Income

$72M20.7% margin

EPS (Diluted)

$3.68

Cash Flow

Operating Cash Flow

$155M

Free Cash Flow

-$347M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.9B

Stockholders' Equity

$564M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$348M	$294M	+18.4%
Gross Profit	$169M	$137M	+23.1%
Operating Income	$106M	$66M	+60.2%
Net Income	$72M	$6M	+1101.6%

CAI FY 2017 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena